405 related articles for article (PubMed ID: 24733273)
41. Association Between the hOGG1 1245C>G (rs1052133) Polymorphism and Susceptibility to Colorectal Cancer: a Meta-analysis Based on 7010 Cases and 10,674 Controls.
Ghelmani Y; Asadian F; Antikchi MH; Dastgheib SA; Shaker SH; Jafari-Nedooshan J; Neamatzadeh H
J Gastrointest Cancer; 2021 Jun; 52(2):389-398. PubMed ID: 33025423
[TBL] [Abstract][Full Text] [Related]
42. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis.
Zheng Y; Wang JJ; Sun L; Li HL
Mol Biol Rep; 2012 Apr; 39(4):3533-40. PubMed ID: 21710246
[TBL] [Abstract][Full Text] [Related]
43. COX-2 gene rs689466 polymorphism is associated with increased risk of colorectal cancer among Caucasians: a meta-analysis.
Zhang YC; Zhao H; Chen C; Ali MA
World J Surg Oncol; 2020 Jul; 18(1):192. PubMed ID: 32731879
[TBL] [Abstract][Full Text] [Related]
44. MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case-control studies.
Sheng X; Zhang Y; Zhao E; Lu S; Zheng X; Ge H; Lu W
Mol Biol Rep; 2012 Oct; 39(10):9669-79. PubMed ID: 22729883
[TBL] [Abstract][Full Text] [Related]
45. Influence of the Cyclooxygenase-2 Gene -765G/C and -1195G/A Polymorphisms on Development of Ischemic Stroke.
Wu G; Cai H; Cai H; Chen Z; Tan L; Qin X; Cai Y
J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):2126-35. PubMed ID: 27363623
[TBL] [Abstract][Full Text] [Related]
46. Association of rs2233678 and rs2233679 polymorphisms in the PIN1 gene with cancer risk: a meta-analysis.
Zhenzhen L; Ning S; Xianghua L
Tumour Biol; 2014 Jan; 35(1):433-40. PubMed ID: 23982872
[TBL] [Abstract][Full Text] [Related]
47. Cyclooxygenase-2 polymorphisms were associated with the risk of gastric cancer: evidence from a meta-analysis based on case-control studies.
Yan WF; Sun PC; Nie CF; Wu G
Tumour Biol; 2013 Dec; 34(6):3323-30. PubMed ID: 23775011
[TBL] [Abstract][Full Text] [Related]
48. Association of folate intake, dietary habits, smoking and COX-2 promotor -765G>C polymorphism with K-ras mutation in patients with colorectal cancer.
Kamal MM; Youssef OZ; Lotfy AN; Elsaed ET; Fawzy MM
J Egypt Natl Canc Inst; 2012 Sep; 24(3):115-22. PubMed ID: 22929917
[TBL] [Abstract][Full Text] [Related]
49. Bone morphogenetic protein-4 polymorphism and colorectal cancer risk: a meta analysis.
Li J; Sun C; Yuan Y; Liu L; Xiong G; Wu J
Mol Biol Rep; 2012 May; 39(5):5239-51. PubMed ID: 22170598
[TBL] [Abstract][Full Text] [Related]
50. SMAD7 polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.
Huang Y; Wu W; Nie M; Li C; Wang L
Oncotarget; 2016 Nov; 7(46):75561-75570. PubMed ID: 28070019
[TBL] [Abstract][Full Text] [Related]
51. The roles of ADIPOQ rs266729 and MTNR1B rs10830963 polymorphisms in patients with gestational diabetes mellitus: A meta-analysis.
Bai Y; Tang L; Li L; Li L
Gene; 2020 Mar; 730():144302. PubMed ID: 31884106
[TBL] [Abstract][Full Text] [Related]
52. Association between CD209 -336A/G and -871A/G polymorphisms and susceptibility of tuberculosis: a meta-analysis.
Chang K; Deng S; Lu W; Wang F; Jia S; Li F; Yu L; Chen M
PLoS One; 2012; 7(7):e41519. PubMed ID: 22911807
[TBL] [Abstract][Full Text] [Related]
53. Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies.
Liu L; Miao L; Ji G; Qiang F; Liu Z; Fan Z
Mol Biol Rep; 2013 Jun; 40(6):3943-52. PubMed ID: 23271134
[TBL] [Abstract][Full Text] [Related]
54. Functional polymorphisms of cyclooxygenase-2 gene and risk for hepatocellular carcinoma.
Akkız H; Bayram S; Bekar A; Akgöllü E; Ülger Y
Mol Cell Biochem; 2011 Jan; 347(1-2):201-8. PubMed ID: 21042835
[TBL] [Abstract][Full Text] [Related]
55. The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies.
Tian X; Dai S; Sun J; Jiang S; Jiang Y
Oncotarget; 2017 Jan; 8(1):1156-1165. PubMed ID: 27901479
[TBL] [Abstract][Full Text] [Related]
56. Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case-control studies.
Li Q; Liu L; Liu Y; Zhou H; Yang Z; Yuan K; Min W
Med Oncol; 2015 Jan; 32(1):397. PubMed ID: 25433948
[TBL] [Abstract][Full Text] [Related]
57. E-cadherin (CDH1) gene -160C/A polymorphism and the risk of colorectal cancer: A meta-analysis involving 17,291 subjects.
Ye CC; Wang J
J Gene Med; 2021 Oct; 23(10):e3370. PubMed ID: 34097324
[TBL] [Abstract][Full Text] [Related]
58. Association of Interleukin-10 Polymorphisms with Susceptibility to Colorectal Cancer and Gastric Cancer: an Updated Meta-analysis Based on 106 Studies.
Zare M; Dastgheib SA; Tabatabaie SM; Asadian F; Setayesh S; Mirjalili H; Shaker SH; Sadeghizadeh-Yazdi J; Neamatzadeh H
J Gastrointest Cancer; 2022 Dec; 53(4):1066-1082. PubMed ID: 34694592
[TBL] [Abstract][Full Text] [Related]
59. CYP1B1 Asn453Ser polymorphism and colorectal cancer risk: a meta-analysis.
Mei Q; Zhou D; Han J; Lu H; Tang B
Metabolism; 2012 Sep; 61(9):1321-9. PubMed ID: 22459615
[TBL] [Abstract][Full Text] [Related]
60. IRS-2 rs1805097 polymorphism is associated with the decreased risk of colorectal cancer.
Yin J; Zhang Z; Zheng H; Xu L
Oncotarget; 2017 Apr; 8(15):25107-25114. PubMed ID: 28212577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
